Pitney Bowes opened higher at $16.00, compared with its previous close of $15.94. In the last trading session, the stock traded between $15.63 and $16.02. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Pitney Bowes is now worth
$ 197.54
Giving a profit of
$ 97.54 (97.54%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 1 Analysts
Buy
0%
Hold
100%
Sell
0%
Markets Today
Today's Change
$-0.30 (-1.85%)
Day High
$16.02
Day Low
$15.63
Day Open
$16.00
Prev Close
$15.94
Volume
7,42,125
1W Return
-2.29%
1M Return
-7.67%
3M Return
-5.51%
6M Return
-1.60%
1Y Return
65.73%
Fundamentals
Market Cap ($ Mn)
2,121
PE Ratio
13.99
PB Ratio
-
PEG Ratio
0.24
ROE
-
ROCE
16.88%
EPS (TTM)
$0.39
Investment Returns
1 Week
-2.29%
1 Month
-7.67%
3 Months
-5.51%
6 Months
-1.60%
9 Months
51.16%
Financials
Quarterly
All values in $ Mn
461.9
Jun 25
459.7
Sep 25
477.6
Dec 25
477.4
Mar 26
451.5
Jun 26
456.2
Sep 26
Updates
21Sep
Pitney Bowes accepts $46.5m in notes tender offer
Pitney Bowes accepted $46.5 million in notes via cash tender offers expiring September 18, 2026. The company targeted up to $50 million in aggregate principal amount across two note series. Acceptances included $40.8 million of 6.70% Notes due 2043 and $5.7 million of 5.25% Notes due 2037. All validly tendered notes were accepted, avoiding pro-rata allocation complexities.
1mo ago
20Aug
Pitney Bowes launches $50m cash tender for 2043, 2037 notes
Pitney Bowes Inc. initiated cash tender offers for up to $50 million in aggregate principal of its 6.70% Notes due 2043 and 5.250% Notes due 2037. The offers expire on September 18, 2026, with settlement expected on September 22, 2026. The company plans to fund the buyback using cash on hand, prioritizing the 2043 Notes for acceptance.
2mo ago
30Jul
Pitney Bowes Latest Results: EPS guidance raised to $1.55-$1.70 range
Pitney Bowes raises FY2026 adjusted EPS guidance to $1.55-$1.70, beating the $1.62 estimate. The company affirms its sales outlook of $1.800B-$1.860B, which is in line with the $1.843B estimate. The EPS increase suggests improved margins rather than top-line growth.
3mo ago
3Jul
Pitney Bowes explores strategic alternatives including full sale
Pitney Bowes Inc. has commenced the second phase of its strategic review process to evaluate a full range of alternatives, including acquisitions, divestitures, partnerships, and a potential full sale of the company. The review will be conducted by the Board of Directors and a newly formed Strategic Review Committee, comprised entirely of independent board members, alongside independent financial and legal advisors.
